date founded

General

About Company
NGT Biopharma Consultants provides strategic and operational consultancy for the development of small molecule and biologic drug candidates.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2018

IPO status

Private

Description

The company partners with CROs and CDMOs to offer a full range of services from late-stage discovery to life-cycle management. Additionally, NGT Biopharma Consultants provides consultancy services focused on analytical, processing, and digital technology platforms for biopharmaceutical drug manufacturing. They also offer innovative facility design strategies to support a post-pandemic supply chain model.
Contacts
Similar Companies
1000
Exemplify Biopharma

Exemplify Biopharma

Exemplify BioPharma is a provider of integrated CMC management and functional support services for drug developers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Consulting

Location

Cranbury, NJ, USA
Vakzine Projekt Management GmbH

Vakzine Projekt Management GmbH

VPM is a German-based provider of tailor-made consultancy and services for biopharmaceutical development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Consulting

Location

Hanover, Germany
KLIFO

KLIFO

KLIFO is a drug development consulting firm that partners with biotech and pharmaceutical companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Consulting

Location

2600 Glostrup, Denmark
Xyzagen

Xyzagen

Xyzagen is a contract research and consulting firm that supports early to mid-stage biotech start-ups in their drug development programs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Pittsboro, NC 27312, USA

Financials

Co-Investors

People

Employee Profiles
1
Michelle McGuinness

Michelle McGuinness

Vice President, Regulatory Strategy & Submissions

Activity

Recent News
0